Post Hoc Analysis of MRD Negativity After End of Induction in the Phase 3 PhALLCON Trial


Por: Aldoss, I, Vachhani, P, Kantarjian, H, Montesinos, P, Leonard, J, Gomez-Almaguer, D, Baer, MR, Gambacorti-Passerini, C, Mccloskey, J, Minami, Y, Papayannidis, C, Rocha, V, Rousselot, P, Wang, ENC, Hennessy, M, Vorog, A, Patel, N, Santasusana, JMR and Jabbour, E

Publicada: 1 sep 2025
Resumen:


Filiaciones:
Aldoss, I:
 City Hope Duarte, Duarte, CA USA

Vachhani, P:
 Univ Alabama Birmingham, Birmingham, AL USA

Kantarjian, H:
 Univ Texas MD Anderson Canc Ctr, Houston, TX USA

Montesinos, P:
 Hosp Univ & Politecn La Fe Valencia, Valencia, Spain

Leonard, J:
 Oregon Hlth & Sci Univ, Portland, OR USA

Gomez-Almaguer, D:
 UANL, Hosp Univ, Monterrey, Mexico

Baer, MR:
 Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD USA

Gambacorti-Passerini, C:
 Univ Milano Bicocca, Monza, Italy

Mccloskey, J:
 Hackensack Univ, Med Ctr, Hackensack, NJ USA

Minami, Y:
 Natl Canc Ctr Hosp East, Kashiwa, Japan

Papayannidis, C:
 IRCCS Azienda Osped Univ Bologna Ist Ematol Seragn, Bologna, Italy

Rocha, V:
 Univ Sao Paulo, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil

Rousselot, P:
 Hosp Mignot Univ Versailles St Quentin En Yvelines, Paris, France

Wang, ENC:
 Roswell Pk Comprehens Canc Ctr, Leukemia Serv, Buffalo, NY USA

Hennessy, M:
 Takeda Dev Ctr Amer Inc, Cambridge, MA USA

Vorog, A:
 Takeda Dev Ctr Amer Inc, Cambridge, MA USA

Patel, N:
 Takeda Dev Ctr Amer Inc, Cambridge, MA USA

:
 ICO Hosp Germans Trias & Pujol, Barcelona, Spain

Jabbour, E:
 Univ Texas MD Anderson Canc Ctr, Houston, TX USA
ISSN: 21522650





Clinical Lymphoma Myeloma & Leukemia
Editorial
Cancer Media Group, 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 25 Número:
Páginas:
WOS Id: 001606305100048

MÉTRICAS